A consent management platform is HIPAA-compliant when it does two specific things: it signs a business associate agreement (BAA) covering the consent layer it runs for you, and it actually blocks analytics and advertising trackers until a visitor consents. A banner that only records a preference while the trackers fire underneath it does not qualify, whatever the marketing page says. Very few tools do both, and the ones built for healthcare are usually enterprise platforms sold through a sales team.
Key Takeaways
- 01A consent management platform is HIPAA-compliant only when it does two things: signs a business associate agreement (BAA) covering the consent layer, and actually blocks analytics and ad trackers until a visitor consents.
- 02A cookie banner alone is not HIPAA authorization. Many banners sit on the page while the trackers behind them fire before anyone clicks, which is the pattern behind the healthcare pixel-tracking lawsuits.
- 03Purpose-built healthcare platforms (Freshpaint, Ours Privacy) sign BAAs but are enterprise, sales-led CDPs. Most mainstream cookie-consent tools market themselves as HIPAA-aligned but will not sign a real BAA, or gate it behind an enterprise contract.
- 04ConsentStack signs a BAA on its published $79/mo Business plan, self-serve and without an enterprise contract, and blocks trackers until consent. As far as we have found, it is the only consent tool that advertises a BAA on a self-serve plan.
- 05A BAA covers the consent layer only. It does not by itself make your whole site HIPAA compliant. Your analytics, CRM, and other vendors still need their own BAAs.
If you run a clinic, a telehealth service, a dental or therapy practice, or any health-related site, this matters more than it looks. The trackers on your website are the exact thing behind the pixel-tracking lawsuits against hospitals and health systems. Here is what actually makes a consent platform HIPAA-ready, what to look for when you compare them, and where ConsentStack fits.
What a HIPAA-compliant consent platform actually is
There is no such thing as a HIPAA-certified cookie banner. HIPAA does not certify software. It governs how covered entities and their business associates handle protected health information (PHI). A consent platform enters that picture because, on a health-related site, the tracking it manages can transmit PHI. When someone reads a page about a condition or books an appointment, the analytics and ad tags on that page can send the page viewed and the visitor's IP address to third parties, and on a health site that browsing data can be PHI. The vendor handling those tags is then acting as your business associate. So for a consent tool, HIPAA-compliant means two things in practice: it will sign a BAA to take on that role, and it genuinely stops the tracking until the visitor agrees.
Why a cookie banner alone is not enough
This is the trap. Plenty of banners sit on the page while the trackers behind them load immediately, before anyone clicks a thing. The banner records a choice; the data already left. For a marketing site that is sloppy. For a health-related site it is the precise fact pattern regulators and plaintiffs have gone after, because the pre-consent request transmits the visitor's IP and the page they viewed to a third party that has not signed a BAA. The question is never whether you have a banner. It is whether tracking is actually held until consent, which is rarer than it sounds.
Clicking Accept on a cookie banner is not the same as a patient authorizing the disclosure of their health information. A banner can be part of a compliant setup, but only when it truly blocks tracking until consent and the vendor behind it has signed a BAA. On its own, it is decoration.
The two requirements, and what to look for
Strip away the marketing and a HIPAA-appropriate consent platform comes down to a short checklist. Use it to compare any tool you are evaluating.
| What to check | Why it matters for HIPAA | Common reality |
|---|---|---|
| Signs a BAA for the consent layer | Without a BAA, the vendor legally cannot handle data that may be PHI | Most self-serve tools will not; the ones that do usually require an enterprise contract |
| Blocks trackers before consent | A request fired pre-consent transmits IP and page viewed to a third party, which is the violation | Many banners are decorative and trackers fire anyway |
| Keeps trackers off on Reject | A reject that still leaks defeats the purpose | Often only a consent-mode signal is sent, not real blocking |
| Keeps an audit trail of consent | You have to be able to prove what a visitor agreed to and when | Healthcare-focused tools do this well; general banners vary |
| Available without a sales cycle | A small practice needs to close the gap now, not negotiate procurement | HIPAA-grade tools are typically enterprise and sales-led |
The first two rows are the ones that decide it. A tool that fails either one cannot make a health site's tracking HIPAA-appropriate, whatever else it offers.
Where the market actually stands
Two kinds of tools clear the bar, and they sit at opposite ends. Purpose-built healthcare platforms like Freshpaint and Ours Privacy sign BAAs and route tracking server-side so data stops when someone opts out. They are genuinely capable and genuinely enterprise: sold through a sales team, priced for larger organizations, and often more machinery than a single practice or clinic needs. At the other end, most mainstream cookie-consent tools market themselves as HIPAA-aligned but either will not sign a BAA at all, or gate it behind an enterprise contract you have to negotiate. For the full picture of which consent tools sign a BAA and on what terms, see our survey of which cookie consent tools sign a BAA.
How ConsentStack fits (and where it doesn't)
ConsentStack sits in the gap between those two ends. It blocks analytics and advertising trackers until a visitor consents, keeps them off when someone clicks Reject, and it will sign a BAA covering that consent layer. The difference is how you get it: the BAA comes on the published Business plan at $79 a month, self-serve, with no enterprise contract and no sales call. As far as we have found, it is the only consent tool that advertises a BAA on a self-serve plan. For a small or mid-size healthcare site that needs real blocking and a signed BAA without an enterprise CDP's price tag, that is the whole point.
It is not the whole compliance story, and we are clear about that. For the healthcare-specific detail, pixels stopping on Reject, audit logs, and the exact BAA scope, the healthcare consent page goes deeper. For how the rule itself treats website tracking, see our HIPAA overview.
ConsentStack's BAA names it as your business associate for the consent layer it operates for you. Your analytics, CRM, email platform, and other vendors each still need their own BAA. A consent tool with a BAA closes the tracking-before-consent gap. It does not, by itself, make your site HIPAA compliant.
Check what your site does before consent
Before you compare tools, see what your current site actually does. Run it through our free compliance scanner and watch exactly which trackers fire before and after someone clicks Reject. It takes about a minute and does not ask for an email. On a health-related site, that report is the fastest way to find out whether your banner is holding tracking back or just sitting on top of it.
HIPAA and consent management FAQ
Two things: it signs a business associate agreement (BAA) covering the consent layer, and it actually blocks analytics and advertising trackers until a visitor consents. A tool that fails either one cannot make a health site's tracking HIPAA-appropriate.
No. A banner that records a choice while trackers fire underneath it does not meet the standard, and it is the pattern behind the healthcare pixel-tracking lawsuits. The banner has to genuinely hold tracking until consent, and the vendor behind it has to have signed a BAA.
Purpose-built healthcare platforms like Freshpaint and Ours Privacy do, as enterprise products. Most mainstream cookie-consent tools do not, or only on an enterprise contract. ConsentStack signs one on its published $79/mo Business plan. See our BAA survey for the full list.
No. A BAA covers the specific vendor relationship it names, in this case the consent layer. Your analytics, CRM, email, and other vendors each still need their own BAA, and the BAA is one part of a broader HIPAA program.
Healthcare-specific platforms are typically enterprise-priced and sold through sales. ConsentStack includes the BAA on its self-serve Business plan at $79 a month, so a smaller healthcare site can get real blocking and a signed BAA without an enterprise contract.
If analytics or ad tags on health-related pages can transmit a visitor's browsing data before consent, the vendor handling them is acting as your business associate, and a BAA plus real consent blocking is what closes that gap. ConsentStack signs a BAA for the consent layer on its $79/mo Business plan.
See what your site leaks before consent
Run a free compliance scan for HIPAA-relevant tracking and EU/US rules. See exactly what fires before anyone clicks Accept, and what still fires after Reject. No signup.
Related Posts
Which Cookie Consent Tools Sign a BAA? (2026)
Most cookie banners won't sign a BAA, and the ones that do usually gate it behind an enterprise contract. Here's who signs one, what it takes, and how ConsentStack does it on a published $79/mo plan.
Is Mailchimp HIPAA Compliant? (2026)
No. Mailchimp signs no BAA on any plan and its terms prohibit protected health information, so covered entities cannot use it for PHI. Here is what to use instead, and the website-tracking gap most healthcare sites miss.
How Cookie Consent Script Blocking Actually Works (And Why Most CMPs Fake It)
Most CMPs display a banner while tracking scripts fire freely. A technical breakdown of the three script blocking approaches and why only parse-time blocking actually works.